Prior to his current position, Richard was VP Global Commercial leader in the global Rare Disease Unit
GSK appoints Dr Richard Jones to VP, Medicine Commercialisation Leader, Haematology
Prior to his current position, Richard was VP Global Commercial leader in the global Rare Disease Unit
Tags
Related posts
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
